Session Information

HomeProgramSession Information ▶ Educational Grant Support Acknowledgements
Educational Grant Support Acknowledgements

The American Thoracic Society gratefully acknowledges the following companies for educational and in-kind grant support of its educational programming. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests.

All grants are developed and submitted after content is approved and programmed by the ATS International Conference Committee. All granting relationships are between the companies that support education and the American Thoracic Society, and are within the Standards for Commercial Support from the American Council for Continuing Medical Education and the Council of Medical Specialty Societies Code of Conduct, which the ATS signed in October 2010.

The following companies have provided educational grants in support of courses offered at ATS 2019. Please see details below for all specific courses supported by these companies. **Companies providing $100,000 or more in educational grant support are noted in bold text.

  • Actelion Pharmaceuticals US, Inc.
  • AstraZeneca LP
  • Bayer US
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Boston Scientific Corporation
  • Genentech, Inc.
  • GlaxoSmithKline
  • Insmed Incorporated
  • Mallinckrodt Pharmaceuticals
  • Novartis Pharmaceuticals Corporation
  • Olympus Corporation of the Americas
  • Sanofi Genzyme and Regeneron Pharmaceuticals
  • United Therapeutics Corporation
  • Vertex Pharmaceuticals, Inc.

 

The following companies have provided in-kind support by loaning equipment or donating materials for use in educational courses offered at ATS 2019. Please see details below for specific courses supported. **Companies supporting more than one course are noted in bold text.

  • Abbott
  • Ambu
  • BD
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Boston Scientific Corporation
  • CAE Healthcare, Blue Phantom
  • Clement Clarke
  • Cook Medical
  • Edwards Lifesciences LLC
  • ERBE USA, Inc.
  • Fisher & Paykel Healthcare
  • FUJIFILM Sonosite, Inc.
  • Getinge
  • GE Healthcare
  • GlaxoSmithKline
  • Hill-Rom
  • MCG Diagnostics
  • Mindray
  • Medtronic
  • Merit Medical Endotek
  • Monaghan Medical Corporation
  • Mylan Pharmaceuticals Inc.
  • ndd Medical Technologies, Inc.
  • Olympus Corporation of the Americas
  • Philips
  • Philips Respironics
  • RedMed
  • SunMed
  • Sunovion Pharmaceuticals, Inc.
  • Teleflex Incorporated
  • Teva Pharmaceuticals
  • Verathon
  • Vyaire Medical

Educational Grant Support by Session

The American Thoracic Society would like to thank all of the below companies for their generous support of our educational programming at ATS 2019.

Friday, May 17, 2019

PG1A – “Critical Care Ultrasound and Echocardiography I”
In-Kind Support: CAE Healthcare, Blue Phantom, Cook Medical, FUJIFILM SonoSite, Inc., GE Healthcare, Mindray, Philips, Teleflex Incorporated

PG2 – “ECMO for Experienced Providers”
In-Kind Support: Abbott, FujiFilm SonoSite, Inc., Getinge

PG6 – “Interstitial Lung Disease: Current Trends in Diagnosis and Management”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals

PG8 – “Proceedings from the World Symposium 2018: What Do We Need to Know Moving Forward?”
Educational Grant Support: Actelion Pharmaceuticals US, Inc., Bayer US, United Therapeutics Corporation

PG9 - "Functional Assessments in Lung Disease: Strength, Activity and Cardiopulmonary Exercise Testing with Case Conference"
In-Kind Support: MCG Diagnostics

PG12 – “State-of-the-Art: Lung Cancer 2019”
Educational Grant Support: AstraZeneca LP, Genentech, Inc.

Saturday, May 18, 2019

PG1B – “Critical Care Ultrasound and Echocardiography II”
In-Kind Support: CAE Healthcare, Blue Phantom, Cook Medical, FUJIFILM SonoSite, Inc., GE Healthcare, Mindray, Philips, Teleflex Incorporated

PG13 – “Bronch Day 2019: A Comprehensive, Hands-On Guide to Basic Bronchoscopy, EBUS, and Navigational Bronchoscopy”
Educational Grant Support: Boston Scientific Corporation, Olympus Corporation of the Americas
In-Kind Support: Boston Scientific Corporation, Cook Medical, Edwards LifeSciences LLC, ERBE USA, Inc., Medtronic, Olympus Corporation of the Americas, SunMed, Teleflex Incorporated, Verathon

PG14 – “Asthma State of the Art 2019”
Educational Grant Support: Genentech, Inc., GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals

PG16 – “Interstitial Lung Disease: Delivering Optimal, Patient Centered Care”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc.

PG24 – “Pulmonary Function Testing in The Real World: 2019 Updates on the Art and Science of PFT”
In-Kind Support: MCG Diagnostics

ATS 2019 Fellows Track Symposium
Educational Grant Support: Actelion Pharmaceuticals US, Inc., AstraZeneca LP, Genentech, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Olympus Corporation of the Americas, Vertex Pharmaceuticals, Inc.
In-Kind Support: FUJIFILM SonoSite, Inc, ndd Medical Technologies, Inc., Olympus Corporation of the Americas

ATS 2019 Resident Boot Camp Program
Educational Grant Support: Olympus Corporation of the Americas
In-Kind Support: Ambu, BD, Boehringer Ingelheim Pharmaceuticals, Inc., Clement Clarke, Cook Medical, ERBE USA, Inc., Fisher & Paykel Healthcare, FUJIFILM SonoSite, Inc., Getinge, GlaxoSmithKline, Hill-Rom, Medtronic, Mindray, Monaghan Medical Corporation, Mylan Pharmaceuticals Inc., ndd Medical Technologies, Inc., Olympus Corporation of the Americas, Philips Respironics, SunMed, Sunovion Pharmaceuticals, Inc., Teleflex Incorporated, Teva Pharmaceuticals, Verathon, Vyaire Medical

Sunday, May 19, 2019

A1- "Clinical Year in Review 1"
Educational Grant Support: GlaxoSmithKline

A3 – “When There is No Right Answer: A Pro/Con Debate on Controversies in ILD”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc.

A8 – “Crossing the Border: Mildly Increased Pulmonary Artery Pressure and the New Definition of Pulmonary Hypertension”
Educational Grant Support: Actelion Pharmaceuticals US, Inc., Bayer US, United Therapeutics Corporation

A9 – “Novel Biomakers for the Diagnosis, Phenotyping, and Management of Pediatric Lung Diseases”
Educational Grant Support: GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals

A81 – “Pediatric Year in Review”
Educational Grant Support: Insmed Incorporated, Vertex Pharmaceuticals, Inc.

A82 – “Cystic Fibrosis: Heterogeneity in a Monogenetic Disease”
Educational Grant Support: Vertex Pharmaceuticals, Inc.

CC1 – “Pulmonary Clinical Core Curriculum I”

Educational Grant Support: Genentech, Inc., Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals

Monday, May 20, 2019

B1 – “Clinical Year in Review 2”
Educational Grant Support: Genentech, Inc., GlaxoSmithKline, Insmed Incorporated, Mallinckrodt Pharmaceuticals, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals

B8 – “Ensuring Broad Dissemination and Equitable Access to Lung Cancer Screening: Challenges and Opportunities”
Educational Grant Support: AstraZeneca LP, Genentech, Inc.

B87 – “Crosstalk Between Airway Epithelium and Type 2 Immunity in Asthma”
Educational Grant Support: Genentech, Inc., GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals

CC3 – “Pulmonary Clinical Core Curriculum II”
Educational Grant Support: Genentech, Inc., GlaxoSmithKline, Insmed Incorporated, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals

Tuesday, May 21, 2019

C1 – “Clinical Year in Review 3”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc., Genentech, Inc.

C3 – “Evidence in Asthma COPD Overlap: Clinical and Molecular Studies to Advance Treatment”
Educational Grant Support: Genentech, Inc., GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals

C7 – “Pulmonologists Need to Know About Cancer Immunotherapy”
Educational Grant Support: AstraZeneca LP, Genentech, Inc.

C8 – “Bronchiectasis: Moving Beyond the Vicious Cycle”
Educational Grant Support: Insmed Incorporated

C9 – “Difficult to Treat Asthma in the Pediatric Population”
Educational Grant Support: Genentech, Inc., GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals              

C11 – “Future Directions in PAH Research: A Pro/Con Debate”
Educational Grant Support: Actelion Pharmaceuticals US, Inc., Bayer US, United Therapeutics Corporation

C82 – “Challenges in the Long-Term Clinical Management of Sarcoidosis”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals

C91 – "Improving Care Quality While Reducing Cost: Is High Value Care for COPD Achievable?
Educational Grant Support: GlaxoSmithKline

Wednesday, May 22, 2019

D1 - “Clinical Year in Review 4”
Educational Grant Support: Actelion Pharmaceuticals US, Inc., AstraZeneca LP, Bayer US, Genentech, Inc., United Therapeutics Corporation

D3 – "Rurality in COPD: Defining the Problem and Deploying Novel Care Delivery Approaches"
Educational Grant Support: GlaxoSmithKline

D82 – “Autoimmune Associated ILD: A Case Based Approach to Diagnosis and Treatment”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc., Genentech, Inc.

D83 – “New Advances in the Bronchoscopic Diagnosis and Treatment of Lung Cancer”
Educational Grant Support: AstraZeneca LP, Boston Scientific Corporation, Olympus Corporation of the Americas

CC6 – "Critical Care Clinical Core Curriculum II"
Educational Grant Support: GlaxoSmithKline